» Articles » PMID: 35625929

Hepatitis B Virus Variants with Multiple Insertions And/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients

Abstract

Deletions in the 3' end region of the hepatitis B virus (HBV) X open reading frame () may affect the core promoter (Cp) and have been frequently associated with hepatocellular carcinoma (HCC). The aim of this study was to investigate the presence of variants with deletions and/or insertions (Indels) in this region in the quasispecies of 50 chronic hepatitis B (CHB) patients without HCC. We identified 103 different Indels in 47 (94%) patients, in a median of 3.4% of their reads (IQR, 1.3-8.4%), and 25% (IQR, 13.1-40.7%) of unique sequences identified in each quasispecies (haplotypes). Of those Indels, 101 (98.1%) caused 44 different altered stop codons, the most commonly observed were at positions 128, 129, 135, and 362 (putative position). Moreover, 39 (37.9%) Indels altered the TATA-like box (TA) sequences of Cp; the most commonly observed caused TA2 + TA3 fusion, creating a new putative canonical TATA box. Four (8%) patients developed negative clinical outcomes after a median follow-up of 9.4 (8.7-12) years. In conclusion, we observed variants with Indels in the 3' end in the vast majority of our CHB patients, some of them encoding alternative versions of HBx with potential functional roles, and/or alterations in the regulation of transcription.

Citing Articles

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA.

Wooddell C, Sanders D, Xu Z, Mak L, Schluep T, Seto W Viruses. 2025; 16(12.

PMID: 39772249 PMC: 11680220. DOI: 10.3390/v16121943.


Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.

Yan W, Rao D, Fan F, Liang H, Zhang Z, Dong H Front Oncol. 2024; 14:1407434.

PMID: 38962270 PMC: 11220127. DOI: 10.3389/fonc.2024.1407434.


Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases.

Wang J Biomedicines. 2023; 11(4).

PMID: 37189758 PMC: 10135662. DOI: 10.3390/biomedicines11041140.

References
1.
Mouzakis K, Lang A, Vander Meulen K, Easterday P, Butcher S . HIV-1 frameshift efficiency is primarily determined by the stability of base pairs positioned at the mRNA entrance channel of the ribosome. Nucleic Acids Res. 2012; 41(3):1901-13. PMC: 3561942. DOI: 10.1093/nar/gks1254. View

2.
Ma N, Lau S, Hu L, Xie D, Wu J, Yang J . COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res. 2008; 14(16):5061-8. DOI: 10.1158/1078-0432.CCR-07-5082. View

3.
Peng Y, Liu B, Hou J, Sun J, Hao R, Xiang K . Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy. Antivir Ther. 2015; 20(6):623-32. DOI: 10.3851/IMP2955. View

4.
Angers S, Li T, Yi X, MacCoss M, Moon R, Zheng N . Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature. 2006; 443(7111):590-3. DOI: 10.1038/nature05175. View

5.
Ponjavic J, Lenhard B, Kai C, Kawai J, Carninci P, Hayashizaki Y . Transcriptional and structural impact of TATA-initiation site spacing in mammalian core promoters. Genome Biol. 2006; 7(8):R78. PMC: 1779604. DOI: 10.1186/gb-2006-7-8-R78. View